Pliant Therapeutics (PLRX) Research & Development (2020 - 2025)
Historic Research & Development for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to $17.9 million.
- Pliant Therapeutics' Research & Development fell 6243.67% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.4 million, marking a year-over-year decrease of 1914.17%. This contributed to the annual value of $169.3 million for FY2024, which is 3248.35% up from last year.
- Per Pliant Therapeutics' latest filing, its Research & Development stood at $17.9 million for Q3 2025, which was down 6243.67% from $32.2 million recorded in Q2 2025.
- In the past 5 years, Pliant Therapeutics' Research & Development registered a high of $47.8 million during Q3 2024, and its lowest value of $17.9 million during Q3 2025.
- In the last 5 years, Pliant Therapeutics' Research & Development had a median value of $29.3 million in 2023 and averaged $29.7 million.
- As far as peak fluctuations go, Pliant Therapeutics' Research & Development skyrocketed by 4766.69% in 2024, and later crashed by 6243.67% in 2025.
- Quarter analysis of 5 years shows Pliant Therapeutics' Research & Development stood at $18.8 million in 2021, then skyrocketed by 33.93% to $25.1 million in 2022, then surged by 32.13% to $33.2 million in 2023, then increased by 16.91% to $38.8 million in 2024, then plummeted by 53.76% to $17.9 million in 2025.
- Its Research & Development was $17.9 million in Q3 2025, compared to $32.2 million in Q2 2025 and $43.4 million in Q1 2025.